Serum leukocyte cell-derived chemotaxin-2 (Lect-2) levels in osteoarthritis patients
Bu makale için 30 Eylül 2025 tarihinde bir düzeltme yayımlandı. https://dergipark.org.tr/tr/pub/cumj/article/1790568
Abstract
Purpose: An association between the complimentary system and osteoarthritis is becoming more apparent. Lect-2 protein acts as a regulator of immunological and inflammatory responses. This study aims to determine the levels of leukocyte cell-derived chemotaxin-2 (Lect-2) in patients with osteoarthritis.
Materials and Methods: The study included 38 osteoarthritis patients and 36 healthy controls. ESR, WBC, serum CRP and Lect-2 levels were measured both in patients and controls.
Results: ESR and serum CRP levels were significantly higher in patients compared to controls. The mean Lect-2 level in osteoarthritis patients (14.2±4.8 ng/mL) was significantly lower compared to the healthy control group (56.3±20.7 ng/mL). ROC analysis revealed that serum LECT-2 level was a significant parameter in determining patients from healthy controls. Cut off value was ≤24.8 ng/mL with a high AUC (0.990).
Conclusion: The significant reduction in Lect-2 levels in osteoarthritis patients suggests its potential role in disease pathogenesis. This finding may contribute to understanding the immunological aspects of osteoarthritis and could potentially serve as a biomarker for disease progression. Further studies with larger patient populations are needed to validate these findings and explore the therapeutic implications of Lect-2 in osteoarthritis management.
Keywords
Kaynakça
- Yang CZ, Zhang YY, Zheng M. Soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in synovial fluid are correlated with disease severity of knee osteoarthritis. Clin Biochem. 2011;44:1094-6.
- Chen D, Shen J, Zhao W, Wang T, Han L, Hamilton JL et al. Osteoarthritis: toward a comprehensive understanding of pathological mechanism. Bone Res. 2017;5:1-13.
- de Oliveira PSS, Cardoso PRG, de Paula Silva SK, Duarte ALBP, da Rosa MM, de Melo Rêgo MJB et al. High serum levels of galectins 1 and 4 in osteoarthritis patients. Clin Biochem. 2023;116:11-5.
- Yao Q, Wu X, Tao C, Gong W, Chen M, Qu M et al. Osteoarthritis: pathogenic signaling pathways and therapeutic targets. Signal Transduct Target Ther. 2023;8:56.
- Xia B, Chen D, Zhang J, Hu S, Jin H, Tong P. Osteoarthritis pathogenesis: a review of molecular mechanisms. Calcif Tissue Int. 2014;95:495-505.
- Toegel S, Bieder D, André S, Altmann F, Walzer SM, Kaltner H et al. Glycophenotyping of osteoarthritic cartilage and chondrocytes by RT-qPCR, mass spectrometry, histochemistry with plant/human lectins and lectin localization with a glycoprotein. Arthritis Res Ther. 2013;15:R147.
- Zheng R, Zhang Y, Zhang K, Yuan Y, Jia S, Liu J. The complement system, aging, and aging-related diseases. Int J Mol Sci. 2022;23:8689.
- Wang Q, Xu F, Chen J, Xie YQ, Xu SL, He WM. Serum leukocyte cell-derived chemotaxin 2 (LECT2) level is associated with osteoporosis. Lab Med. 2023;54:106-11.
- Zhu MH, Liu YJ, Li CY, Tao F, Yang GJ, Chen J. The emerging roles of leukocyte cell-derived chemotaxin-2 in immune diseases: From mechanisms to therapeutic potential. Front Immunol. 2023;14:1158083.
- Ikeda D, Ageta H, Tsuchida K, Yamada H. iTRAQ-based proteomics reveals novel biomarkers of osteoarthritis. Biomarkers. 2013;18:565-72.
